Biopharma Market Update – June 5, 2025

Stifel's Biopharma Market Update - June 5, 2025

Stifel’s ASCO 2025 recap and oncology market update, incorporating DealForma data, highlights the rise of bispecific and ADC-based therapies, shifting pharma buyer strategies, and China’s growing prominence in oncology licensing and innovation. Read it here

DealForma Research

Explore More
Cancer R&D Partnerships, M&A and Venture Funding by Tech - Q1 2025 Review

Cancer R&D Partnerships, M&A and Venture Funding by Tech – Q1 2025 Review

Cancer R&D Partnerships, M&A and Venture Funding Activity by TA - Q1 2025

Cancer R&D Partnerships, M&A and Venture Funding Activity by TA – Q1 2025

MedTech, Device, Digital Health, and Wearables M&A and Ventures – Q1 2025

MedTech, Device, Digital Health, and Wearables M&A and Ventures – Q1 2025

All of this by stage, disease indication, modality, target…

Schedule your Demo
+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures
DealForma Logo

DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.

Linkedin

Database

Company

Comparisons

Website Design by Once Interactive